Group 1 - The core point of the article is that Berry Genomics (000710) announced the establishment of a joint venture, Henan Yiyuan Tongkang Gene Technology Co., Ltd., with an investment of 600,000 yuan from its subsidiary Berry Health and a partner, Li Wei [1] - The registered capital of the joint venture is set at 1 million yuan, focusing on integrated testing services for genetic diseases in newborns and children, in collaboration with public medical institutions and clinical medical enterprises in key regions such as Henan [1] - The joint venture plans to increase its operating capital through capital increases based on business progress, with an expected registered capital of no less than 50 million yuan if the future business performance meets expectations [1]
贝瑞基因:子公司拟设合资公司 开展新生儿及儿童基因病一体化检测服务